RxDoctor Payments Data

Fahad Laghari

Vascular Neurology · Tucson, AZNPI 1750810404

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,847 of the $15,407 with a category attached, or 70.4%. 13 manufacturers reported payments, led by Stryker at 55.4% of the total. 2025 is the largest year on record at $7,121, more than ten times the $142 reported in 2022.

$15,407in general payments, 2019–2025

Across 398 payments — averaging $38.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$9K
  • Penumbra, Inc.$2K
  • Johnson & Johnson$2K
  • Scientia Vascular$893
  • Balt USA, LLC$843
  • Medical Device Business Services, Inc.$417
  • plus $1K from 7 others
$30in research payments, 2019–2025

Across 1 payment — averaging $30.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sim&cure Inc$30

What the payments were for

  • Consulting fees$8005%
  • Travel & lodging$3,76024%
  • Food & beverage$10,84770%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few vascular neurology providers in Arizonato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$20,272
Medicare patients
109
Services billed
182

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor22$16,308
Atorvastatin Calcium11$108

Paid to pharmacies, not to this prescriber.

Other vascular neurology in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →